Nosratola D Vaziri Selected Research

Azotemia

8/2013	Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy.
1/2013	Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.
10/2012	Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis--role of intra-renal angiotensin system.
1/2012	Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy.
6/2011	Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
12/2010	High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.
10/2010	High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.
10/2009	Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.
7/2009	Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
6/2009	Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nosratola D Vaziri Research Topics

Disease

98	Inflammation (Inflammations) 02/2021 - 02/2003
72	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 09/2001
64	Chronic Renal Insufficiency 01/2023 - 09/2001
61	Hypertension (High Blood Pressure) 12/2019 - 01/2002
45	Proteinuria 01/2023 - 01/2002
38	Fibrosis (Cirrhosis) 01/2023 - 09/2004
20	Anemia 01/2020 - 05/2004
19	Atherosclerosis 08/2014 - 09/2004
18	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 05/2004
18	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 01/2002
17	Hypercholesterolemia 04/2014 - 05/2002
15	Hypertriglyceridemia 01/2021 - 01/2002
15	Kidney Diseases (Kidney Disease) 01/2021 - 04/2004
13	Azotemia 08/2013 - 11/2005
12	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2002
11	Hypoalbuminemia 01/2021 - 05/2002
11	Renal Insufficiency (Renal Failure) 01/2019 - 01/2002
11	Uremia 12/2017 - 01/2010
10	Obesity 01/2021 - 03/2002
10	Body Weight (Weight, Body) 01/2019 - 03/2002
9	Dysbiosis 01/2021 - 01/2017
9	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2010
8	Iron Overload 07/2019 - 04/2012
7	Insulin Resistance 02/2021 - 10/2004
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2013
6	Cachexia 01/2021 - 12/2010
5	Ischemia 01/2019 - 02/2005
5	Hyperphosphatemia 01/2019 - 01/2011
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 08/2013 - 01/2002
4	Ureteral Obstruction 10/2022 - 07/2009

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2001
36	AntioxidantsIBA 01/2023 - 09/2001
32	LipidsIBA 01/2023 - 03/2002
24	CholesterolIBA 01/2018 - 05/2002
23	CreatinineIBA 01/2023 - 01/2002
21	EnzymesIBA 04/2020 - 01/2003
21	IronIBA 01/2020 - 05/2004
21	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2001
18	HDL LipoproteinsIBA 01/2016 - 05/2003
17	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2006
17	NF-kappa B (NF-kB)IBA 01/2019 - 01/2004
17	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 01/2002
16	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2008
16	Lipoproteins (Lipoprotein)IBA 01/2018 - 03/2002
16	oxidized low density lipoproteinIBA 10/2016 - 03/2002
14	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2014 - 01/2003
13	Superoxide DismutaseIBA 01/2023 - 01/2003
12	Triglycerides (Triacylglycerol)IBA 01/2016 - 03/2002
11	Uremic ToxinsIBA 02/2021 - 01/2014
11	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 09/2001
11	VLDL LipoproteinsIBA 01/2016 - 01/2002
11	3-nitrotyrosineIBA 01/2012 - 09/2001
10	HDL CholesterolIBA 10/2019 - 03/2002
10	Fatty Acids (Saturated Fatty Acids)IBA 07/2017 - 07/2004
10	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 07/2004
9	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2019 - 02/2009
9	EndotoxinsIBA 11/2017 - 01/2012
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2004
8	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2021 - 01/2002
8	Glutathione PeroxidaseIBA 04/2020 - 01/2003
8	Phosphates (Orthophosphate)IBA 01/2020 - 01/2011
8	Erythropoietin FDA Link 01/2020 - 05/2004
8	Angiotensin IIIBA 01/2018 - 06/2002
8	CatalaseIBA 05/2015 - 01/2003
8	LDL Receptors (LDL Receptor)IBA 04/2014 - 07/2003
7	Adenine FDA LinkGeneric 10/2022 - 01/2012
7	CateninsIBA 09/2019 - 01/2017
7	TriterpenesIBA 02/2018 - 01/2013
7	CarbohydratesIBA 01/2017 - 03/2002
7	SaltsIBA 06/2014 - 03/2003
6	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2022 - 01/2019
6	Resistant StarchIBA 11/2020 - 01/2014
6	AmmoniaIBA 01/2017 - 01/2013
6	Interleukin-6 (Interleukin 6)IBA 10/2016 - 12/2005
6	bardoxolone methylIBA 01/2014 - 10/2012
6	Insulin (Novolin)FDA Link 01/2013 - 07/2002
6	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2013 - 05/2002
5	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 09/2002
5	Messenger RNA (mRNA)IBA 01/2023 - 05/2002
5	Dimethyl FumarateIBA 01/2021 - 01/2014
5	ferric citrateIBA 01/2020 - 01/2016
5	HematinicsIBA 07/2019 - 04/2012
5	Transcription Factors (Transcription Factor)IBA 01/2019 - 10/2005
5	ReninIBA 01/2018 - 06/2002
5	IDL Lipoproteins (Lipoprotein, IDL)IBA 01/2016 - 09/2010
5	LDL CholesterolIBA 04/2014 - 03/2002
5	Chylomicron RemnantsIBA 04/2014 - 11/2009
5	ChylomicronsIBA 04/2014 - 03/2005
5	AngiotensinsIBA 10/2012 - 10/2006
5	Glutathione (Reduced Glutathione)IBA 08/2011 - 03/2002
5	Liver X ReceptorsIBA 10/2010 - 01/2009
5	VLDL receptorIBA 11/2009 - 01/2002
5	Superoxides (Superoxide)IBA 01/2009 - 01/2003
5	Cholesterol 7-alpha-Hydroxylase (Cholesterol 7 alpha Hydroxylase)IBA 12/2005 - 05/2002
4	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 01/2003

Therapy/Procedure

35	Therapeutics 01/2023 - 09/2001
25	Renal Dialysis (Hemodialysis) 01/2023 - 04/2009
8	Nephrectomy 01/2023 - 10/2009
5	Diet Therapy (Therapy, Diet) 02/2019 - 08/2002
5	Peritoneal Dialysis 01/2019 - 01/2013